Vor Biopharma Inc. Common Stock
XNAS:VOR
17.18
$17.10 - 125.00
$16.30 - 12.00
$16.4
$17.64
$17.17
$17.27
65.8
2.62
704986
1126915.8
17360622.89
Chart
TendieTensor AI Analysis
Company
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Fundamentals
168
-0.040000
-0.070000
100
BBG00NBJRDT6
BBG00NBJRDV3
6.85M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own VOR. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.